METASTATIC OSTEOSARCOMA
Clinical trials for METASTATIC OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Immune-Boosting combo targets Tough-to-Treat bone and soft tissue cancers
Disease control OngoingThis study is testing whether two immunotherapy drugs, oleclumab and durvalumab, can help control advanced sarcomas that have come back, stopped responding to treatment, or spread. The drugs aim to help the patient's own immune system recognize and attack the cancer cells. The tr…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for teens fighting relapsed bone cancer
Disease control OngoingThis study is testing an oral drug called cabozantinib to see if it can control the growth of two aggressive bone cancers, osteosarcoma and Ewing sarcoma, in young patients whose cancer has returned or spread after standard treatment. The drug works by blocking signals tumors nee…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Doctors test inhaled cancer treatment to target lung tumors
Disease control OngoingThis early-stage study is testing an inhaled form of an immune-boosting drug (aldesleukin) for people whose cancer has spread to their lungs. The main goals are to find a safe dose and see if the treatment causes side effects. Researchers also want to learn if inhaling the drug d…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC